Literature DB >> 15036147

Organelle robbery: Brucella interactions with the endoplasmic reticulum.

Jean Celli1, Jean-Pierre Gorvel.   

Abstract

Brucella is an intracellular pathogen that survives and multiplies inside host macrophages to cause brucellosis. The underlying mechanisms of intracellular survival, including the bacterial and the host determinants remain relatively unknown. Recent advances have helped to decipher how Brucella controls the biogenesis of its intramacrophagic replicative organelle. Brucella initially avoids or escapes the endocytic pathway to ensure its intracellular survival, which is then further secured via the biogenesis of an endoplasmic reticulum-derived replicative organelle. A major virulence factor, the VirB type IV secretion system, is required for sustained interactions and fusion with the host endoplasmic reticulum.

Entities:  

Mesh:

Year:  2004        PMID: 15036147     DOI: 10.1016/j.mib.2003.11.001

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  42 in total

1.  Attenuated bioluminescent Brucella melitensis mutants GR019 (virB4), GR024 (galE), and GR026 (BMEI1090-BMEI1091) confer protection in mice.

Authors:  Gireesh Rajashekara; David A Glover; Menachem Banai; David O'Callaghan; Gary A Splitter
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 2.  ppGpp conjures bacterial virulence.

Authors:  Zachary D Dalebroux; Sarah L Svensson; Erin C Gaynor; Michele S Swanson
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

3.  Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.

Authors:  M M Kahl-McDonagh; T A Ficht
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  The Brucella suis type IV secretion system assembles in the cell envelope of the heterologous host Agrobacterium tumefaciens and increases IncQ plasmid pLS1 recipient competence.

Authors:  Anna Carle; Christoph Höppner; Khaled Ahmed Aly; Qing Yuan; Amke den Dulk-Ras; Annette Vergunst; David O'Callaghan; Christian Baron
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 5.  Biological diversity of prokaryotic type IV secretion systems.

Authors:  Cristina E Alvarez-Martinez; Peter J Christie
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

6.  Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.

Authors:  Edurne Imbuluzqueta; Carlos Gamazo; Hugo Lana; Miguel Ángel Campanero; David Salas; Ana Gloria Gil; Elisa Elizondo; Nora Ventosa; Jaume Veciana; María J Blanco-Prieto
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

7.  Evidence of Brucella abortus OPS dictating uptake and restricting NF-kappaB activation in murine macrophages.

Authors:  Jianwu Pei; Joshua E Turse; Thomas A Ficht
Journal:  Microbes Infect       Date:  2008-01-20       Impact factor: 2.700

8.  Subversion of innate immune responses by Brucella through the targeted degradation of the TLR signaling adapter, MAL.

Authors:  Dola Sengupta; Alicia Koblansky; Jennifer Gaines; Tim Brown; A Phillip West; Dekai Zhang; Tak Nishikawa; Sung-Gyoo Park; R Martin Roop; Sankar Ghosh
Journal:  J Immunol       Date:  2009-12-14       Impact factor: 5.422

9.  Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo.

Authors:  Marina A Durward; Jerome Harms; Diogo M Magnani; Linda Eskra; Gary A Splitter
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

10.  BtaE, an adhesin that belongs to the trimeric autotransporter family, is required for full virulence and defines a specific adhesive pole of Brucella suis.

Authors:  Verónica Ruiz-Ranwez; Diana M Posadas; Charles Van der Henst; Silvia M Estein; Gastón M Arocena; Patricia L Abdian; Fernando A Martín; Rodrigo Sieira; Xavier De Bolle; Angeles Zorreguieta
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.